CASE REPORT

Airborne Fungi in Chronic Rhinosinusitis Patients Maxillary Sinus Lavage at Dr. Saiful Anwar Hospital Malang

Iriana Maharani , Rus Suheryanto, Endang Retnoningsih

Iriana Maharani
Brawijaya University, Malang, Indonesia. Email: mh4r4n1@hotmail.com

Rus Suheryanto
Brawijaya University, Malang, Indonesia

Endang Retnoningsih
Brawijaya University, Malang, Indonesia
Online First: May 08, 2016 | Cite this Article
Maharani, I., Suheryanto, R., Retnoningsih, E. 2016. Airborne Fungi in Chronic Rhinosinusitis Patients Maxillary Sinus Lavage at Dr. Saiful Anwar Hospital Malang. Bali Medical Journal 5(2): 209-215. DOI:10.15562/bmj.v5i2.181


Background: Chronic rhinosinusitis has a significant impact on the quality of life and health of adult population. Role of airborne fungi remains a controversy and have become the source of discussion for decades. Objective to know the prevalence of airborne fungi in the chronic rhinosinusitis with or without polyps patients and to know the possible effect of airborne fungi on chronic rhinosinusitis inflammation. Methods: This is a cross sectional research in the Saiful Anwar Public Hospital Malang, there were 29 patients involved. We examine fungi culture, H&E staining and DNA fungi by using PCR from sinus lavage sample. From the blood serum we examine allergen specific IgE, IgG3, IL-13 and IL-5. Results: Fungi culture there were 31,03 % of sample growth but only matches the PCR result in 3 samples (10,34 %). From PCR examinations we found all sample were positive with 2-5 species fungi, Alternaria alternata was found positive in 24,13% samples. There was an increment of IgE allergen specific and IL-5, a decrement of IL-13 and IgG3 in all of our samples regardless presence of nasal polyps and species of fungi found in PCR. Conclusions: PCR is a more reliable method compare to fungal culture. The presence of fungi in all of our samples could indicate fungi contribution to the disease pathophysiology. The increased level of Il-5 was not followed by IL-13; it may happen through PRR pathway. 

Keywords


References

Sacks P-L, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Antifungal Therapy in The Treatment of Chronic Rhinosinusitis: A meta-analysis. Am J Rhinol Allergy. 2012; 26:141-147.

Chakrabarti A, Das A, Panda NK. Controversies Surrounding the Categorization of Fungal Sinusitis. Medical Mycology. 2008 [cited 31/12/2012]; 47:299-308.

Jain S, Das S, Gupta N, Malik JN. Frequency of Fungal Isolation and Antifungal Susceptability Pattern of the Fungal Isolates from Nasal Polyps of Chronic Rhinosinusitis Patients at a Tertiary Care Centre in North India. Medical Mycology. 2012; EO:1-6.

Pakdaman MN, Corry DB, Luong A. Fungi Linking the Pathophysiology of Chronic Rhinosinusitis with Nasal Polyps and Allergic Asthma. Imunological Investigations. 2011; 40:767-785.

Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi-Peters A, et al. Perspectives on the Etiology of Chronic Rhinosinusitis: An Immune Barrier Hypothesis. Am J Rhinol Allergy. 2008 [cited 4/1/2013]; 22(6):549-559.

Ponikau JU, Sherris DA, Kita H. The Role of Ubiquitous Airborne Fungi in Chronic Rhinosinusitis. In: Hamilos DL, Baroody FM, editors. Chronic Rhinosinusitis: Pathogenesis and Medical Management. New York: Informa Healthcare USA, Inc.; 2007. p. 177-184.

Ebbens F, Georgalas C, Rinia A, Drunen Cv, Lund V, Fokkens W. The Fungal Debate: Where Do We Stand Today? Rhinology. 2007 [cited 31/12/2012]; 45:178-189

Dennis DP. Chronic Sinusitis: Defective T-Cells Responding to Superantigens, Treated by Reduction of Fungi in the Nose and Air. Archives of Enviromental Health. 2003 [cited 31/12/2012]; 58(7):433-440.

Mor N, Sherris DA, Kita H, Ponikau JU. Understanding the Role of Fungi in the Pathophysiology and Treatment of Chronic Rhinosinusitis. US Respiratory Disease. 2007.

Glass D, Amedee RG. Allergic Fungal Rhinosinusitis: A Review. The Ochsner Journal 11:271–275, 2011.

Meulenbroek A.J, Zeijlemaker W.P , Nieuwenhuys E. Human IgG Subclasses. Useful Diagnostic Markers for Immunocompetence. Sanquin formerly CLB (Centraal Laboratorium van de Bloedtransfusiedienst). http://ednieuw.home.xs4all.nl/IgGsubclasses/subkl3.htm. [cited 31/12/2014]

Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine Levels in the Serum of Healthy Subjects. Mediators of Inflammation Journal. 2013

Cain RB, Lal B. Update on the Management of chronic Rhinosinusitis. Infection and Drug Resistance. 2013 : 6 (1-4)

Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl D, Burner H. Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy 2005; 35:1186–1191

Mor N, Sherris DA, Kita H, Ponikau JU. Understanding the Role of Fungi in the Pathophysiology and Treatment of Chronic Rhinosinusitis. US RESPIRATORY DISEASE. 2007.

Hoan NTK, Karmochkineb M, Laccourreyea O, Bonfilsa P. Nasal polyposis and immunoglobulin-G subclass deficiency. European Annals of Otorhinolaryngology, Head and Neck diseases 131 (2014) 171–175

Armenaka M, Grizzanti J, Rosenstreich DL. Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Annals of Allergy. 72(6):507-514. 1994

Ocampo CJ, Peters AJ. Antibody deficiency in chronic rhinosinusitis: Epidemiology

and burden of illness. Am J Rhinol Allergy 27, 34–38, 2013.

Pant, H., Kette, F. E., Smith, W. B., Wormald, P. J. and Macardle, P. J. Fungal-Specific Humoral Response in Eosinophilic Mucus Chronic Rhinosinusitis. The Laryngoscope, 115: 601–606. 2005

Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, Environmental Fungi Induce Activation and Degranulation of Human Eosinophils. The Journal of Immunology.2005; 175:5439-5447


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0